The U.S. National Security Commission on Emerging Biotechnology issued its first report since its creation through the National Defense Authorization Act of FY2022.
U.S. Senator Todd Young (R-Ind.), a commissioner on the bipartisan U.S. National Security Commission on Emerging Biotechnology, today issued the following statement regarding the release of the Commission’s interim report examining the critical intersection of emerging biotechnology and national security: “Biotechnology presents tremendous opportunities for life sciences, manufacturing, agriculture, defense, and many other fields. Preserving
The Northern Virginia Chamber of Commerce and Professional Services Council announce class number 21 of the companies and executives as winners of the G.